Parallel Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Parallel Advisors, LLC

$4.31 Billion
Q1 2025

A detailed history of Parallel Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 59 shares of ARWR stock, worth $977. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1,133 94.79%

Holding current value

$977

Previous $21,000 100.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 07, 2025	SELL	$12.74 - $21.53 $13,682 - $23,123	-1,074 Reduced 94.79%	59 $0
Q4 2024 Feb 10, 2025	BUY	$17.7 - $26.34 $16,230 - $24,153	917 Added 424.54%	1,133 $21,000
Q3 2024 Nov 13, 2024	BUY	$19.36 - $29.54 $1,180 - $1,801	61 Added 39.35%	216 $4,000
Q2 2024 Aug 08, 2024	SELL	$21.87 - $28.24 $9,579 - $12,369	-438 Reduced 73.86%	155 $4,000
Q1 2024 May 06, 2024	BUY	$27.21 - $39.48 $1,278 - $1,855	47 Added 8.61%	593 $16,000
Q4 2023 Feb 09, 2024	BUY	$21.2 - $31.03 $11,575 - $16,942	546 New	546 $16,000
Q2 2023 May 20, 2024	SELL	$25.16 - $41.38 $930 - $1,531	-37 Reduced 68.52%	17 $0
Q2 2023 Aug 04, 2023	SELL	$25.16 - $41.38 $930 - $1,531	-37 Reduced 68.52%	17 $0
Q1 2023 May 20, 2024	SELL	$23.68 - $38.51 $12,763 - $20,756	-539 Reduced 90.89%	54 $1,000
Q1 2023 Apr 25, 2023	SELL	$23.68 - $38.51 $21,548 - $35,044	-910 Reduced 94.4%	54 $1,000
Q4 2022 Feb 03, 2023	BUY	$28.0 - $40.56 $4,620 - $6,692	165 Added 20.65%	964 $39,000
Q3 2022 Nov 10, 2022	BUY	$29.63 - $48.31 $533 - $869	18 Added 2.3%	799 $26,000
Q2 2022 Aug 01, 2022	BUY	$27.79 - $50.61 $2,084 - $3,795	75 Added 10.62%	781 $27,000
Q1 2022 Apr 28, 2022	SELL	$39.62 - $69.97 $4,477 - $7,906	-113 Reduced 13.8%	706 $32,000
Q4 2021 Jan 20, 2022	BUY	$58.09 - $82.51 $41,940 - $59,572	722 Added 744.33%	819 $54,000
Q3 2021 Nov 02, 2021	SELL	$58.38 - $84.96 $8,406 - $12,234	-144 Reduced 59.75%	97 $6,000
Q2 2021 Aug 06, 2021	BUY	$62.15 - $90.32 $4,536 - $6,593	73 Added 43.45%	241 $20,000
Q1 2021 Apr 23, 2021	SELL	$61.35 - $90.47 $27,239 - $40,168	-444 Reduced 72.55%	168 $11,000
Q4 2020 Feb 02, 2021	BUY	$43.82 - $85.37 $24,232 - $47,209	553 Added 937.29%	612 $47,000
Q2 2020 Jul 16, 2020	BUY	$26.12 - $43.27 $914 - $1,514	35 Added 145.83%	59 $2,000
Q1 2020 Apr 27, 2020	BUY	$20.56 - $63.12 $493 - $1,514	24 New	24 $0

Others Institutions Holding ARWR

# of Institutions

300

Shares Held

98M

Call Options Held

306K

Put Options Held

432K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.75B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History